News & Press Releases

Integrity Applications Names Prof. Lutz Heinemann to Advisory Board

February 27th, 2015

Integrity Applications Names Prof. Lutz Heinemann to Advisory Board   Preeminent Expert In Diabetes Study Will Head New Advisory Board   ASHKELON, Israel, February 26, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack® model DF-F, a noninvasive   device that tracks blood glucose levels, announced today that Dr. […]

Read More

Integrity Applications Signs Distribution Agreements for Its GlucoTrack® Model DF-F Glucose Monitoring Device in Hong-Kong and China

February 19th, 2015

Integrity Applications Signs Distribution Agreements for Its GlucoTrack® Model DF-F Glucose Monitoring Device in Hong-Kong and China   Noninvasive Blood Glucose Measurement Device For Diabetes   ASHKELON, Israel, February 17, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, […]

Read More

Archive

Sign up to our newsletter
To receive occasional news updates

LinkedIn Facebook Twitter

GlucoTrack® intended use: GlucoTrack® Model DF-F is a non-invasive intermittent glucose monitoring device for home-use. GlucoTrack® model DF-F is intended for adults 18 years and older with type 2 diabetes or pre-diabetes.

Medications intake and/or treatment decisions should not be based solely on GlucoTrack® model DF-F measurements. GlucoTrack® Model DF-F is a glucose monitoring device and should not be used for diagnosis purposes.

© 2019 Integrity Applications. All Rights Reserved.